Validation of genomic and transcriptomic models of homologous recombination deficiency in a real-world pan-cancer cohort.

Autor: Leibowitz BD; Tempus Labs, 600 W Chicago Ave Ste #510, Chicago, IL, 60654, United States., Dougherty BV; Tempus Labs, 600 W Chicago Ave Ste #510, Chicago, IL, 60654, United States., Bell JSK; Tempus Labs, 600 W Chicago Ave Ste #510, Chicago, IL, 60654, United States., Kapilivsky J; Tempus Labs, 600 W Chicago Ave Ste #510, Chicago, IL, 60654, United States., Michuda J; Tempus Labs, 600 W Chicago Ave Ste #510, Chicago, IL, 60654, United States., Sedgewick AJ; Tempus Labs, 600 W Chicago Ave Ste #510, Chicago, IL, 60654, United States., Munson WA; Tempus Labs, 600 W Chicago Ave Ste #510, Chicago, IL, 60654, United States., Chandra TA; Tempus Labs, 600 W Chicago Ave Ste #510, Chicago, IL, 60654, United States., Dry JR; Tempus Labs, 600 W Chicago Ave Ste #510, Chicago, IL, 60654, United States., Beaubier N; Tempus Labs, 600 W Chicago Ave Ste #510, Chicago, IL, 60654, United States., Igartua C; Tempus Labs, 600 W Chicago Ave Ste #510, Chicago, IL, 60654, United States., Taxter T; Tempus Labs, 600 W Chicago Ave Ste #510, Chicago, IL, 60654, United States. tim@tempus.com.

Publikováno v: BMC cancer [BMC Cancer] 2022 May 28; Vol. 22 (1), pp. 587. Date of Electronic Publication: 2022 May 28.